Skip to main navigation Skip to search Skip to main content

Megakaryocytes possess a STING pathway that is transferred to platelets to potentiate activation

  • Firas El-Mortada
  • , Karima Landelouci
  • , Samuel Bertrand-Perron
  • , Félix Antoine Aubé
  • , Amélie Poirier
  • , Amel Bidias
  • , Georges Jourdi
  • , Mélanie Welman
  • , Michael P. Gantier
  • , Justin R. Hamilton
  • , Benjamin Kile
  • , Marie Lordkipanidzé
  • , Geneviève Pépin

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Platelets display unexpected roles in immune and coagulation responses. Emerging evidence suggests that STING is implicated in hypercoagulation. STING is an adaptor protein downstream of the DNA sensor cyclic GMP-AMP synthase (cGAS) that is activated by cytosolic microbial and self-DNA during infections, and in the context of loss of cellular integrity, to instigate the production of type-I IFN and pro-inflammatory cytokines. To date, whether the cGAS-STING pathway is present in platelets and contributes to platelet functions is not defined. Using a combination of pharmacological and genetic approaches, we demonstrate here that megakaryocytes and platelets possess a functional cGAS-STING pathway. Our results suggest that in megakaryocytes, STING stimulation activates a type-I IFN response, and during thrombopoiesis, cGAS and STING are transferred to proplatelets. Finally, we show that both murine and human platelets contain cGAS and STING proteins, and the cGAS-STING pathway contributes to potentiation of platelet activation and aggregation. Taken together, these observations establish for the first time a novel role of the cGAS-STING DNA sensing axis in the megakaryocyte and platelet lineage.

Original languageEnglish
Number of pages11
JournalLife Science Alliance
Volume7
Issue number2
DOIs
Publication statusPublished - 1 Feb 2024

Cite this